The U.K. Technology Strategy Board awarded QuantuMDx a $1.6 million grant to support a project aimed at developing a rapid test for multidrug-resistant tuberculosis. In this project, QuantuMDx's DNA analysis technology and a TB biomarker panel will be joined in a disposable test cartridge for use with QuantuMDx's Q-POC handheld testing tool.

Related Summaries